仅对制药厂、医药研发公司、医药研究所、医院提供信息服务,不对个人提供信息服务!

类别

搜索

地點

訂閱此搜索

5.33 Euro €

药品编号 13706664 持证商 URSAPHARM Arzneimittel GmbH 包装规格 15 ml 产品名 Pollicrom 20mg/ml 剂型 Nasenspray Monopräparat ja 活性物质 Cromoglicinsäure, Dinatriumsalz 需要医生开处方 nein Apothekenpflichtig ja 信息来源:https://www.besamex.de/product/pollicrom-20-mg-ml-nasenspray-loesung.645913.html

· 十一月 20, 2018
9.42 Euro €

药品编号 06697999 持证商 SCHAPER & BRÜMMER GmbH & Co. KG 包装规格 100 St Packungsnorm N3 产品名 Esberitox Tabletten 剂型 Tabletten Pfl. Arzneimittel ja 需要医生开处方 nein Apothekenpflichtig ja 信息来源:https://www.besamex.de/produkt/esberitox-tabletten-100-st-06697999.html

· 十一月 20, 2018
了解卖家

盐酸阿比多尔片 50mg/片,(20片/盒) Arbidol (Арбидол) Hydrochoride Tablets  持证商: Фармстандарт-Лексредства盐酸阿比多尔混悬液 25mg*5mlArbidol powder for suspension for oral administration 25mg/5ml持证商: Фармстандарт-Лексредства

Russia · 俄罗斯 九月 17, 2020
了解卖家

New Drug Application (NDA): 202408Company: ERA PHARMS LLCTreatment for: erpes Simplex Dendritic KeratitisDate of Approval:03/29/2019DrugName:AVACLYRActive Ingredients:ACYCLOVIRStrength:3%Dosage Form:OINTMENTDosage Route:OPHTHALMICTE Code:NoneRLD:YesRS:NoNDC:48102-028-35Approval Letter...

· 五月 13, 2020
了解卖家

New Drug Application (NDA): 210595Company: CIRCASSIATreatment for: Chronic Obstructive Pulmonary DiseaseDate of Approval:03/29/2019DrugName:DUAKLIR PRESSAIRActive Ingredients:ACLIDINIUM BROMIDE; FORMOTEROL FUMARATEStrength:0.4MG/INH;0.012MG/INHDosage Form:POWDER, METEREDDosage Route:I...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 022561Company: EMD SERONO INCTreatment for: Multiple SclerosisDate of Approval:03/29/2019DrugName:MAVENCLADActive Ingredients:CLADRIBINEStrength:10MG Dosage Form:TABLETDosage Route:ORALTE Code:NoneRLD:YesRS:YesNDC:44087-400-11;44087-400-12;44087-400-04;4408...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 206089Company: CLARUSTreatment for: Hypogonadism -- MaleDate of Approval:03/27/2019DrugName:JATENZOActive Ingredients:TESTOSTERONE UNDECANOATEStrength:237MGDosage Form:CAPSULEDosage Route:ORALTE Code:NoneRLD:YesRS:YesNDC:69087-237-12Start Marketing Date: 08...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 206089Company: CLARUSTreatment for: Hypogonadism -- MaleDate of Approval:03/27/2019DrugName:JATENZOActive Ingredients:TESTOSTERONE UNDECANOATEStrength:198MGDosage Form:CAPSULEDosage Route:ORALTE Code:NoneRLD:YesRS:NoNDC:69087-198-12Start Marketing Date: 08-...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 206089Company: CLARUSTreatment for: Hypogonadism -- MaleDate of Approval:03/27/2019DrugName:JATENZOActive Ingredients:TESTOSTERONE UNDECANOATEStrength:158MGDosage Form:CAPSULEDosage Route:ORALTE Code:NoneRLD:YesRS:NoNDC:69087-158-12Start Marketing Date: 08-...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 209884Company: NOVARTISTreatment for: Multiple SclerosisDate of Approval:03/26/2019DrugName:MAYZENTActive Ingredients:SIPONIMOD FUMARIC ACIDStrength:EQ 2MG BASEDosage Form:TABLETDosage Route:ORALTE Code:NoneRLD:YesRS:YesNDC: 0078-0986-15Approval Letter...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 209884Company: NOVARTISTreatment for: Multiple SclerosisDate of Approval:03/26/2019DrugName:MAYZENTActive Ingredients:SIPONIMOD FUMARIC ACIDStrength:EQ 0.25MG BASEDosage Form:TABLETDosage Route:ORALTE Code:NoneRLD:YesRS:NoNDC: 0078-0979-50Approval Lett...

· 五月 12, 2020
了解卖家

New Drug Application (NDA): 211230Company: JAZZTreatment for: Narcolepsy, Obstructive Sleep Apnea/Hypopnea SyndromeDate of Approval:03/20/2019DrugName:SUNOSIActive Ingredients:SOLRIAMFETOL HYDROCHLORIDEStrength:EQ 150MG BASEPackage:100 BottlesDosage Form:TABLETDosage Route:ORALTE Code...

· 五月 12, 2020
Top